Agree lasers, I've been in bios over 20 years and I just stated my opinion in my post. I respect others opinions and everyone has a right to speculate theirs. If or when The trial shows a better response , ONCS could be grabbed by Merck in a heartbeat for at least 6 billion or around $20 per shAre.. It's my opinion and I don't believe it's so far fetched, I was surprised on the gentle attacks from board members , especially. Furby. Merck may want to react on phase 2 results and before ONCS reaches Phase 3 .. Putting the puzzle together with X Merck personnel in Oncs, the legal staff being hired as well as new hires at strategic positions. This screams buyout ( In MyOpinion). Good luck all,Strik
Market Data 
Markets 
